Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy
- 30 June 1993
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 125 (6) , 1691-1697
- https://doi.org/10.1016/0002-8703(93)90760-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of Disopyramide on Systolic and Early Diastolic Time Intervals in Patients with Hypertrophic CardiomyopathyThe Journal of Clinical Pharmacology, 1991
- Chordal geometry determines the shape and extent of systolic anterior mitral motion: In vitro studiesJournal of the American College of Cardiology, 1989
- Disopyramide in hypertrophic cardiomyopathy I. Hemodynamic assessment after intravenous administrationThe American Journal of Cardiology, 1988
- Oral disopyramide therapy for obstructive hypertrophic cardiomyopathyThe American Journal of Cardiology, 1988
- Hypertrophic CardiomyopathyNew England Journal of Medicine, 1987
- Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A reviewProgress in Cardiovascular Diseases, 1985
- Muscular Subaortic StenosisNew England Journal of Medicine, 1982
- Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis.Circulation, 1978
- Beta-adrenergic Blockade in Hypertrophic Obstructive CardiomyopathyBMJ, 1966
- Muscular subaortic stenosis: The interrelation of wall tension, outflow tract “distending pressure” and orifice radiusThe American Journal of Cardiology, 1965